A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE2
Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)
- Status
- TERMINATED
- Phase
- PHASE1
A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Status
- RECRUITING
- Phase
- PHASE3
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Status
- RECRUITING
- Phase
- PHASE3
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)
- Status
- COMPLETED
- Phase
- PHASE1
Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
- Status
- RECRUITING
- Phase
- PHASE3
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1